Cansino Biologics Inc.

This study is testing a new vaccine designed to protect infants from serious bacterial infections like pneumonia and meningitis. About 600 healthy babies in Thailand, starting at 6 weeks old, will receive either the new vaccine or an existing one to compare how well they work and…

This study is testing a new combined vaccine designed to protect infants and young children from six serious diseases: whooping cough, tetanus, diphtheria, Hib, and four types of meningococcal meningitis. The main goal is to check the vaccine's safety and see if it triggers a goo…

This early-stage study is testing a new experimental vaccine designed to protect against tuberculosis (TB). It will involve 36 healthy adults aged 18-49 to check if the vaccine is safe and if it triggers a protective immune response. Participants will receive either one of two do…